scholarly journals Endoscopic biliary drainage for malignant distal biliary obstruction: which is better – ERCP or EUS?

2021 ◽  
Author(s):  
Ji Young Bang ◽  
Robert Hawes ◽  
Shyam Varadarajulu
2012 ◽  
Vol 75 (4) ◽  
pp. AB376
Author(s):  
Yukiko Ito ◽  
Hiroyuki Isayama ◽  
Takeshi Tsujino ◽  
Takashi Sasaki ◽  
Hirofumi Kogure ◽  
...  

Author(s):  
Manuel Puga ◽  
Nat�lia Pallar�s ◽  
Julio Velásquez-Rodríguez ◽  
Albert García-Sumalla ◽  
Claudia F. Consiglieri ◽  
...  

2014 ◽  
Vol 22 (4) ◽  
pp. E12-E21 ◽  
Author(s):  
Hiroshi Kawakami ◽  
Takao Itoi ◽  
Masaki Kuwatani ◽  
Kazumichi Kawakubo ◽  
Yoshimasa Kubota ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Shinichi Morita ◽  
Yasuaki Arai ◽  
Shunsuke Sugawara ◽  
Miyuki Sone ◽  
Yasunari Sakamoto ◽  
...  

Objectives. To compare the use of an antireflux metal stent (ARMS) with that of a conventional covered self-expandable metal stent (c-CSEMS) for initial stenting of malignant distal biliary obstruction (MDBO). Materials and Methods. We retrospectively investigated 59 consecutive patients with unresectable MDBO undergoing initial endoscopic biliary drainage. ARMS was used in 32 patients and c-CSEMS in 27. Technical success, functional success, complications, causes of recurrent biliary obstruction (RBO), time to RBO (TRBO), and reintervention were compared between the groups. Results. Stent placement was technically successful in all patients. There were no significant intergroup differences in functional success (ARMS [96.9%] versus c-CSEMS [96.2%]), complications (6.2 versus 7.4%), and RBO (48.4 versus 42.3%). Food impaction was significantly less frequent for ARMS than for c-CSEMS (P=0.037), but TRBO did not differ significantly between the groups (log-rank test, P=0.967). The median TRBO was 180.0 [interquartile range (IQR), 114.0–349.0] days for ARMS and 137.0 [IQR, 87.0–442.0] days for c-CSEMS. In both groups, reintervention for RBO was successfully completed in all patients thus treated. Conclusion. ARMS offers no advantage for initial stent placement, but food impaction is significantly prevented by the antireflux valve.


2021 ◽  
Vol 10 (19) ◽  
pp. 4619
Author(s):  
Yuki Tanisaka ◽  
Masafumi Mizuide ◽  
Akashi Fujita ◽  
Tomoya Ogawa ◽  
Hiromune Katsuda ◽  
...  

Distal malignant biliary obstruction is caused by various malignant diseases that require biliary drainage. In patients with operable situations, preoperative biliary drainage is required to control jaundice and cholangitis until surgery. In view of tract seeding, endoscopic biliary drainage is the first choice. Since neoadjuvant therapies are being developed, the time to surgery is increasing, especially in pancreatic cancer cases. Therefore, it requires long stent patency. Recently, preoperative biliary drainage using self-expandable metal stents has been reported as a useful modality to secure long stent patency. In patients with unresectable distal malignant biliary obstruction, self-expandable metal stent is the first choice for maintaining long stent patency. Although there are many comparison studies between a covered and an uncovered self-expandable metal stent, their use is still controversial. Recently, endoscopic ultrasound-guided biliary drainage has been performed as an alternative treatment. The clinical success and stent patency are favorable. We should take into consideration that both endoscopic retrograde cholangiopancreatography-guided biliary drainage and endoscopic ultrasound-guided biliary drainage have advantages and disadvantages and chose the drainage method depending on the patient’s situation or the expertise of the endoscopist. Here, we discuss the current status of endoscopic biliary drainage in patients with distal malignant biliary obstruction.


2018 ◽  
Vol 22 (3) ◽  
pp. 509-512
Author(s):  
I.N. Mamontov ◽  
T.I. Tamm ◽  
K. A. Kramarenko ◽  
A. I. Bardiuk

The causes of malignant extrahepatic biliary obstruction (MEBO) are pancreatic head carcinoma, ampulloma, cholangiocarcinoma, gall bladder cancer, less often — metastatic lymph nodes. Endoscopic biliary drainage (EBD) of extrahepatic ducts (ED) including stent placement plays a key role for cholestasis resolving. Aim — to evaluate the effectiveness of EBD in case of MEBO, depending on its level. Data of 36 patients with MEBO treated with EBD were retrospectively analyzed. Statistic methods: mean value and standart diviation were used. Ampulloma was the cause of MEBO in 7 cases, EBD was effective in all of them. Of 18 patients with MEBO at the level of distal 1/3 of ED, EBD was effective in 13. In the case of an MEBO of the middle 1/3of ED, EBD was successful in 3 of 6 patients, in the proximal 1/3 — in 3 out of 5. Thus, endoscopic biliary drainage was successful in 72% cases of malignant biliary obstruction. In case of obstruction at the papilla level, the success of endoscopic drainage has been achieved in all cases. Failure of EBD was due to inability of performing ERCP — mainly in cases of distal obstruction and the inability to get through obstruction — in the middle and proximal sections of the extrahepatic biliary tract.


2020 ◽  
Vol 27 (11) ◽  
pp. 851-859
Author(s):  
Ryo Sugiura ◽  
Masaki Kuwatani ◽  
Shin Kato ◽  
Kazumichi Kawakubo ◽  
Hirofumi Kamachi ◽  
...  

Medicina ◽  
2020 ◽  
Vol 56 (3) ◽  
pp. 114
Author(s):  
Chi-Chih Wang ◽  
Tzu-Wei Yang ◽  
Wen-Wei Sung ◽  
Ming-Chang Tsai

Biliary and pancreatic cancers occur silently in the initial stage and become unresectable within a short time. When these diseases become symptomatic, biliary obstruction, either with or without infection, occurs frequently due to the anatomy associated with these cancers. The endoscopic management of these patients has changed, both with time and with improvements in medical devices. In this review, we present updated and integrated concepts for the endoscopic management of malignant biliary stricture. Endoscopic biliary drainage had been indicated in malignant biliary obstruction, but the concept of endoscopic management has changed with time. Although routine endoscopic stenting should not be performed in resectable malignant distal biliary obstruction (MDBO) patients, endoscopic biliary drainage is the treatment of choice for palliation in unresectable MDBO patients. Self-expanding metal stents (SEMS) have better stent patency and lower costs compared with plastic stents (PS). For malignant hilum obstruction, PS and uncovered SEMS yield similar short-term outcomes, while a covered stent is not usually used due to a potential unintentional obstruction of contralateral ducts.


Sign in / Sign up

Export Citation Format

Share Document